Harrow Health, Inc.
Harrow Health, Inc. (HROW) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · HROW · as of Sep 30, 2025
Ownership Breakdown
208
Institutional Holders
▲ 42 vs Q2
$1.02B
Total Inst. Value
▲ $381.27M vs Q2
37.28M
Shares Outstanding
freeFloat 75.88%
21.27M
13F Shares Held
▲ 207,670 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
HROW largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
OPALEYE MANAGEMENT INC. pharmaceutical preparations | 3.90M | 10.61% | 10.61% | $188.14B | Nov 14, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 2.55M | 6.93% | 6.93% | $122.91B | Nov 12, 2025 | ▼ 14.6K |
VANGUARD GROUP INC pharmaceutical preparations | 1.87M | 5.08% | 5.08% | $90.13B | Nov 7, 2025 | ▲ 1.5K |
PRIVATE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.86M | 5.04% | 5.04% | $89.41B | Nov 14, 2025 | ▼ 89.7K |
STATE STREET CORP pharmaceutical preparations | 794.3K | 2.16% | 2.16% | $38.27B | Nov 14, 2025 | ▲ 21.2K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 775.6K | 2.11% | 2.11% | $37.38B | Nov 12, 2025 | ▼ 35.2K |
ROYCE & ASSOCIATES LP pharmaceutical preparations | 533.0K | 1.45% | 1.45% | $25.68B | Nov 12, 2025 | ▼ 20.7K |
MARSHALL WACE, LLP pharmaceutical preparations | 508.1K | 1.38% | 1.38% | $24.48B | Nov 13, 2025 | ▼ 56.8K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 448.9K | 1.22% | 1.22% | $21.63B | Nov 14, 2025 | ▲ 235.0K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 343.3K | 93.31% | 93.31% | $16.54B | Nov 14, 2025 | ▲ 146.6K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
22
Increased
+1.92M shares7
New Positions
first time holders20
Decreased
−1.71M shares0
Sold Out
fully exitedNet shares change (top 50)
+212.9K
+1.92M / −1.71M
Net new holders
+9
7 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
HROW insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Graves Adrienne L director | May 18, 2026 | Purchase | 1,000 | $31.07 | $31.1K | 1.0K | Form 4 ↗ |
SILVERNAIL LAUREN P director | May 18, 2026 | Purchase | 1,000 | $31.00 | $31.0K | 1.0K | Form 4 ↗ |
Shojaei Amir CHIEF SCIENTIFIC OFFICER | May 15, 2026 | Award | 10,000 | — | — | 10.0K | Form 4 ↗ |
BAUM MARK L CHIEF EXECUTIVE OFFICER | May 14, 2026 | Purchase | 10,000 | $30.20 | $302.0K | 3.00M | Form 4 ↗ |
BOLL ANDREW R. PRESIDENT AND CFO | May 14, 2026 | Purchase | 3,500 | $29.90 | $104.7K | 814.7K | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | Mar 3, 2026 | Sale | 59,000 | $39.15 | $2.31M | 3.76M | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | Mar 4, 2026 | Sale | 134,000 | $39.67 | $5.32M | 3.62M | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | Mar 3, 2026 | Sale | 1,309 | $39.15 | $51.3K | 63.7K | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | Mar 4, 2026 | Sale | 4,263 | $39.67 | $169.1K | 59.4K | Form 4 ↗ |
Opaleye Management Inc. 10 percent owner | Feb 27, 2026 | Sale | 5,000 | $54.18 | $270.9K | 65.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Harrow Health, Inc. (HROW) is primarily owned by institutional investors, who hold approximately 57.1% of total shares outstanding. Company insiders own approximately 24.12%, while retail and public investors account for the remaining 18.81%.
The largest institutional shareholder of Harrow Health, Inc. is OPALEYE MANAGEMENT INC., holding approximately 3.90 million shares — equal to 10.61% of outstanding shares — as of September 30, 2025.
A total of 208 institutional investors currently hold HROW stock, with a combined institutional value of approximately $1.02 billion as of the most recent 13F filing period.
Frequently asked questions
HROW ownershipHarrow Health, Inc. (HROW) is primarily owned by institutional investors, who hold approximately 57.1% of shares. The largest shareholder is OPALEYE MANAGEMENT INC. with a 10.61% stake. Company insiders hold 24.12%. Data sourced from SEC Form 13F as of September 30, 2025.